Unfortunately, end points such as cardiac mortality and rehospitalization for heart failure were not accounted by Seoudy et al. We found that NT-proBNP responders were significantly associated with lower cardiac mortality, but were not associated with rehospitalization for heart failure. This evidence concerns the gene NPPB and heart failure.